Mortality Associated with Metformin Versus Sulfonylurea Initiation: A Cohort Study of Veterans with Diabetes and Chronic Kidney Disease
ConclusionsInitiation of metformin versus a sulfonylurea among individuals with type 2 diabetes and CKD was associated with a substantial reduction in mortality, in terms of both relative and absolute risk reduction. The largest absolute risk reduction was observed among individuals with moderately –severely reduced eGFR (30–44 mL/min/1.73m2).
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
More News: Chronic Kidney Disease | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Internal Medicine | Metformin | Study | Urology & Nephrology